The MIPACT study is a prospective cohort study designed to integrate multiple sources of digital
understand clinical phenotypes. Participants were recruited from Michigan Medicine and the
communities and provided with an Apple Watch series 3 or 4 and an Omron Evolv Wireless Blood
Participants consented to provide access to parts of their electronic medical record and to
provide a blood
sample for laboratory and genetic analyses. Participants were asked to perform regular tasks
breathing, BP monitoring, and quarterly survey completion. The study was funded in part by
Apple, Inc and
performed in partnership with Michigan Medicine.
Displayed on the MIPACT Cohort Identification Toolkit you will find information from the first
90-days of participation for nearly 7,000 participants from the University of Michigan.
heart rate, blood pressure, Apple Watch step count, and Apple Watch distance walking/running is
available for these participants. Clinical conditions for participants were defined using the
and ICD-10 codes below.